popular endocrinology

for nonprofit educational purposes

Surgery of Pituitary Neoplasms:

Endovideomonitoring in Transsphenoidal Surgery of Pituitary Neoplasms

V.Yu. Cherebillo, V.R. Gofman, A.V. Polezhaev, V.A. Manukovsky

Chair of Neurosurgery, Medicomilitary Academy, Saint Petersburg, Russia


Indications for Surgical Treatment of PituitaryAdenomas


There are absolute and particular indications for surgical treatment of different pituitary adenomas.

Absolute indications are irrespective of a degree, to which hormonal activity of tumors is marked, and include:

  1. Vision acuity reduction and narrowing of visual field margins, caused by an extrasellar growth of tumor and compression of the chiasm and optic nerves.

  2. An impaired function of oculomotor nerves, caused by a parasellar growth of tumor.

  3. Impaired liquor discharge, hydrocephalus and intracranial hypertension, caused by impression of tumor into the 3rd ventricle fundus.

  4. Hemorrhage into a tumor.

  5. Nasal liquorrhea, caused by destruction of the saddle fundus and its diaphragm by tumor.

  6. A prolonged growth of tumor in spite of conservative treatment, including radiation therapy.

Particular indications are dependent on clinical manifestations of secreting pituitary adenomas; they are as follows:

  1. For corticotroph adenoma:
    А. Cushing's disease irrespective of a tumor size.
    B. Nelson's syndrome irrespective of a tumor size.

  2. For somatotroph adenoma - acromegaly (as an operation of choice or the first stage; ineffective radiation therapy).

  3. For prolactinoma - ineffective therapy with bromcriptine or other drugs of this group against a background of:
    - marked impotency
    - infertility (in desired pregnancy)
    - insensibility or intolerance to drugs of the bromcriptine group.

  4. For thyrotroph adenoma - progressive thyrotoxicosis (in ineffective conservative treatment).

  5. For gonadotroph adenoma - marked impotency or infertility (in desired pregnancy).

An Approach Choice


In our opinion, there are only three absolute indications for choosing a transcranial approach:

  • A marked parasellar growth with invasion into a cavernous sinus.

  • A marked supraretroantesellar growth with spread into the third and lateral ventricles.

  • Presence of a narrow intersection between suprasellar and infrasellar neoplastic nodes.

A transsphenoidal access should be an approach of choice in all the rest cases.

<< ^^ >>


REFERENCES

  1. Apuzzo M.L.J., Heifetz M.D., Weiss M.H., Kurze T. Neurosurgical endoscopy using the side-viewing telescope // J. Neurosurg.- 1977.- Vol. 46, N 2.- P. 398-400.

  2. Cawley C.M., Tindall G.T. New techniques in managing sellar pathologies through modifications of the traditional transsphenoidal approach // Crit. Rev. Neurosurg.- 1997.- Vol. 7, N 2 .- P. 115-122.

  3. Gamea A., Fathi M., EL-Guindy A. The use of the rigid endoscope in transsphenoidal pituitary surgery // J. Laryngol. Otol.- 1994.- Vol. 108, N 1.- P. 19-22.

  4. Guiot G. Transsphenoidal spproach in surgical treatment of pituitary adenomas: general principles and indications in nonfunctioning adenoma. In: Kohler P.O., Ross G.T. Diagnosis and treatment of pituitary tumors. Amsterdam: Exepta Medica, International Congress Series N 303.- 1973.- P. 159-178.

  5. Hardy J. Transsphenoidal hypophysectomy: neurosurgical techniques // J. Neurosurg.- 1971.- Vol. 34.- P. 582-594.

  6. Heilman C.B., Shucart W.A., Rebeiz E.E. Endoscopic sphenoidotomy approach to the sella // Neurosurgery.- 1997.- Vol. 41, N 3.- P. 602- 607.

  7. Jankowski R., Auque J., Simon C. et al. Endoscopic pituitary tumor surgery // Laryngoscope.- 1992.- Vol.102, N 2.- P. 198-202.

  8. Jho H.D., Carrau R.L., Ko Y., Daly M.A. Endoscopic pituitary surgery: an early experience // Surg. Neurol.- 1997.- Vol. 47, N 3.- P. 213-223.

  9. Rodziewicz G.S., Kelley R.T., Kellman R.M., Smith M.V. Transnasal endoscopic surgery of the pituitary gland: technical note // Neurosurgery.- 1996.- Vol. 39, N 1.- P. 189 - 193.

Growth hormone (GH) is also called somatropin and somatotropin (British: somatotrophin). hGH refers to human growth hormone and is used as an abbreviation for human GH measured in the blood or extracted from human pituitary glands. In 1985, biosynthetic human growth hormone replaced pituitary-derived human growth hormone for therapeutic use in the U.S. and other countries. Biosynthetic human growth hormone, also referred to as recombinant human growth hormone, is also called somatropin (British: somatrophin) and abbreviated as rhGH. Since the mid-1990s the abbreviation HGH has begun to carry paradoxical connotations and now rarely refers to real GH used for indicated purposes. See articles on GH treatment and HGH quackery for fuller discussions of GH therapy and the HGH issue.
(human growth hormone)

home

map link mail

Endocrinology:

Endocrinologists
Endocrine system
Pituitary gland
Pituitary adenoma
Pharmacologic Treatment of Acromegaly
Pituitary tumors- clinical features, diagnosis


Abstracts

Intraoperative endovideomonitoring in transsphenoidal surgery of pituitary adenomas
Drugs and alcohol: Treating and preventing abuse, addiction and their medical consequences


Full Text

Endovideomonitoring in Transsphenoidal Surgery of Pituitary Neoplasms
Diabetes: Etiology, Pathogenesis, Symptoms (glucagon, hormone crust the adrenal glands, the thyroid gland, the hormone of increase)

Google

Hormones:

human growth hormone
liver hormones
pineal hormones
kidney hormones
thyroid hormones
cardiac hormones
gonadal hormones
pituitary hormones
digestive hormones
placental hormones
pancreatic hormones
parathyroid hormones
hypothalamic hormones
adrenal Cortical hormones
adrenal Medullary hormones
hormone balance
Roll inquiry "hormone"

Tablets or capsulesones:

bromocriptine (parlodel)

Women's Health:

alternative medicines used in menopause

Friend:

reference book

If you are concerned about your health, you should consult a doctor

top

Copyright © MedT, 2005. All rights reserved